News

FDA scrutiny of Novavax COVID-19 vaccine sparks uncertainty about other shots
There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from ...
FDA chief says they're looking at whether to approve COVID shots for next winter
The head of the Food and Drug Administration said Tuesday that the agency is now looking at whether it will still approve COVID-19 vaccines for next winter, citing a lack of data on booster shots.
Novavax: Grandiose Ambitions, Smart Strategy, But FDA Decision Adds To Challenges
Novavax shows financial improvement but faces vaccine challenges. Read why I rated NVAX stock as 'Hold' and what risks and ...
FDA appears to be slow-walking vaccine approvals
Former government health officials fear the Trump administration is moving to slow-walk vaccine approvals, including by ...
Health and Me on MSN1d
Right Before Approval, FDA Again Scrutinizes Novavax Covid-19 Vaccine
Novavax is working with the FDA to meet additional requirements and hopes to secure full approval as soon as possible.
STAT2d
U.S. health officials inject new uncertainty into approval process for Covid boosters
Confusion over the FDA delay in granting full approval to Novavax’s Covid-19 vaccine deepened over the weekend, with possible ...
Devdiscourse5d
Novavax Booster's Fate in Limbo: FDA Considers Approval Amid Controversy
The FDA is considering the approval of the Novavax COVID-19 booster after delays amid controversy over its non-mRNA design.
Novavax's stock surges on 'good news' from Food and Drug Administration
Novavax’s protein-based vaccine is only available under a pandemic-era emergency-use authorization, and formal approval from ...